Replies to post #1901 on Lexington Biosciences Inc. (LXGTF)

[StockBro75]

Your're right, 15 years of development at at Berkely labs and thousands of peer reviewed studies re endothelial function is not to be discounted. This was probably taken into account for acceptance into the FDA 510K premarket expedited clearance program.